Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Susceptibility for Entrainment: Role of Ventilator Settings on the Occurrence of Reverse Triggering and Its Physiological Consequences - the SEVeRe Study

NCT06293976 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT06293976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Susceptibility for Entrainment: Role of Ventilator Settings on the Occurrence of Reverse Triggering and Its Physiological Consequences - the SEVeRe Study
Lead sponsor
Unity Health Toronto
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2025
Completion date
March 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiration, artificial, reverse triggering